China Pharma Holdings, Inc. to Report Third Quarter 2010 Financial Results on November 11, 2010

2010-11-03 16:50 1155

HAIKOU CITY, China, Nov. 3, 2010 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its third quarter 2010 financial results before the market opens on Thursday, November 11, 2010.

The Company will hold a conference call at 8:00 am ET on November 11, 2010 to discuss third quarter 2010 results.  Listeners may access the call by dialing 1-800-659-2056 or 1-617-614-2714 for international callers, access code: 56441223. A webcast will also be available through CPHI's website at A replay of the call will be accessible through November 18, 2010 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 99472174.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit


China Pharma Holdings, Inc.

CCG Investor Relations

Phone: +86-898-6681-1730 (China)

Kalle Ahl, Account Manager


Phone: +1-646-833-3417 (New York)


Vivian Chen, Sr. Market Intelligence Exec.

Phone: +1-(646)-701-7445(New York)


Source: China Pharma Holdings, Inc.
Related Stocks: